Plain-English translation of NCT06724718 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After lung surgery, some patients develop an irregular heartbeat called atrial fibrillation, which can be silent and go unnoticed. This trial is testing whether a smartwatch equipped with heart-monitoring technology can catch these irregular rhythms earlier than standard care, helping prevent serious complications like stroke or heart failure.
Irregular heartbeats after lung surgery occur in about 1 in 5 patients and can lead to serious problems if not caught early. Most of the time, patients don't feel symptoms, so doctors need better ways to detect these rhythm problems quickly.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to either wear a smartwatch that monitors your heart rhythm after surgery or receive standard care without the smartwatch. If you're in the smartwatch group, you'll use the device to take regular heart rhythm readings as instructed by the study team. Either way, the research staff will follow up with you to track your recovery and watch for any irregular heartbeats.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
France
Sponsor
Centre Hospitalier Universitaire, Amiens
Collaborators
Clinique Victor Pauchet
Enrollment target
~302 participants
Started
June 2025
Primary completion
July 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pierre Huette, MD
Centre Hospitalier Amiens
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.